1-9 of 9
Yeow-Tee Goh, MBBS,MMed
Close
Sort by
Journal Articles

Risk Factors Associated with Survival Outcome in Patients with Chronic Myeloid Leukaemia in Accelerated Phase Treated with Tyrosine Kinase Inhibitors

Kee Yon, Lionel See, MD, Kok Chong Bernard Yap, MD, Dong-Wook Kim, MD PhD, Hein Than, MBBS, Yeow-Tee Goh, MBBS, MMed
Journal: Blood
Blood (2016) 128 (22): 1222.
https://doi.org/10.1182/blood.V128.22.1222.1222
Published: 2016
Journal Articles

Expanded Phase 1 Study of ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Reveals Significant and Durable Responses in Patients with CML-Chronic Phase with Failure of Prior TKI Therapy

Timothy P. Hughes, MD FRACP, FRCPA, MBBS, FAAHMS, Yeow-Tee Goh, MBBS, MMed, Oliver G. Ottmann, MD, Hironobu Minami, MD PhD, Delphine Rea, MD PhD, Fabian Lang, MD, Michael J. Mauro, MD, Daniel J. DeAngelo, MD PhD, Moshe Talpaz, MD, Andreas Hochhaus, Prof. Dr., Massimo Breccia, MD, Jorge E. Cortes, MD, Michael C. Heinrich, MD, Jeroen Janssen, MD, Juan-Luis Steegmann, MD PhD, François-Xavier Mahon, MD PhD, Raina Duan, PhD, Varsha Iyer, David Hynds, MS, Gary J. Vanasse, MD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 625.
https://doi.org/10.1182/blood.V128.22.625.625
Published: 2016
Journal Articles

ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy

Oliver G. Ottmann, MD, Giuliana Alimena, Daniel J. DeAngelo, MD PhD, Yeow-Tee Goh, MBBS, MMed, Michael C. Heinrich, MD, Andreas Hochhaus, MD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Francois-Xavier Mahon, MD PhD Professor, Michael J. Mauro, MD, Hironobu Minami, MD D.MDSci., Marie Huong Nguyen, MD, Delphine Rea, Juan Luis Steegmann, MD, Arkendu Chatterjee, Varsha Iyer, Noelia Martinez, Gary J. Vanasse, MD, Kim Dong-Wook, MD PhD
Journal: Blood
Blood (2015) 126 (23): 138.
https://doi.org/10.1182/blood.V126.23.138.138
Published: 2015
Journal Articles

Sokal Risk Score Is Superior to Hasford and EUTOS in Determining Survival Outcomes for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

Brian Gabriel Jiang, Dong-Wook Kim, MD, Lee-Yung Shih, MD, Charles Chuah, Hein Than, MD, Ming-Chung Kuo, MD, HuiHua Li, PhD, John Carson Allen, Jr., PhD, Lionel KY See, Bernard KC Yap, Yeow-Tee Goh, MBBS, MMed
Journal: Blood
Blood (2015) 126 (23): 4044.
https://doi.org/10.1182/blood.V126.23.4044.4044
Published: 2015
Journal Articles

Phase 1 Study Update of the Novel Pan-Pim Kinase Inhibitor LGH447 in Patients with Relapsed/ Refractory Multiple Myeloma

Marc S Raab, MD PhD, Enrique M Ocio, Sheeba K. Thomas, MD, Andreas Günther, MD, Yeow-Tee Goh, MBBS,MMed, Daniel Lebovic, MD, Andrzej Jakubowiak, MD PhD, Dongweon Song, F Xiang, Apurva Patel, K. Gary Vanasse, MD, Shaji Kumar, MD
Journal: Blood
Blood (2014) 124 (21): 301.
https://doi.org/10.1182/blood.V124.21.301.301
Published: 2014
Journal Articles

A Phase 2 Study of Panobinostat (PAN) in Combination with Bortezomib (BTZ) in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL)

Yeow-Tee Goh, MBBS,MMed, William YK Hwang, FRCP, FAMS, MMed, MRCP, MBBS, Colin Phipps Diong, Yap chun Hsien, bsc, Kevin Tay, MD, Soon Thye Lim, MBBS, MRCP, Yuh Shan Lee, MBBS, MRCP, Soo Chin Ng, MD, S Fadilah, MBBS, Won Seog Kim, Daryl Tan, MD
Journal: Blood
Blood (2014) 124 (21): 503.
https://doi.org/10.1182/blood.V124.21.503.503
Published: 2014
Journal Articles

Essential Thrombocythaemia in Young Adults: Clinical Characteristics and Outcomes – a Single Center Experience

Grace Kam, MBBS, MRCP, Richard Yiu, Ai Leen Ang, MBBS, MMed, (Internal, Medicine), Yvonne SM Loh, MBBS, MRCP, Yeh Ching Linn, MBBS, Lai Heng Lee, MBBS, MMed, Yeow Tee Goh, MBBS, MMed, Gee Chuan Wong, MBBS, MRCP, FRCP
Journal: Blood
Blood (2012) 120 (21): 5060.
https://doi.org/10.1182/blood.V120.21.5060.5060
Published: 2012
Journal Articles

Evaluation of Human Polyomavirus (BKV)–Specific T Cell Immune Reconstitution in Allogeneic Haematopoietic Stem Cell Transplant Recipients,

Francesca Lorraine Wei Inng Lim, MBBS, MRCP, MMED, Ai Ling Teo, BSc, Yvonne SM Loh, MBBS, MRCP, William YK Hwang, MBBS, FRCP, FAMS, Yeow-Tee Goh, MBBS, MMed, Khoon Lin Ling, MBBS, MRCP, Yeh Ching Linn, MD
Journal: Blood
Blood (2011) 118 (21): 3223.
https://doi.org/10.1182/blood.V118.21.3223.3223
Published: 2011
Journal Articles

A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia

Axel M Hillmer, PhD, King-Pan Ng, PhD, Charles Chuah, MBChB, FRCPE, MD, Wen Chun Juan, B.Sc, Tun-Kiat Ko, PhD, Audrey S.M. Teo, M.Sc, Pramila N Ariyaratne, M.Sc, Naoto Takahashi, MD, PhD, Kenichi Sawada, MD, PhD, Yao Fei, M.Sc, Wah Heng Lee, PhD, Weijie Huang, B.Sc, John C Allen, Jr., PhD, Xing Yi Woo, PhD, Niranjan Nagarajan, PhD, Vikrant Kumar, PhD, Anbupalam Thalamuthu, PhD, Wan Ting Poh, B.S, Ai Leen Ang, MBBS, MMed, (Internal, Medicine), Hae Tha Mya, M.B.B.S, Gee Fung How, PhD, Li Yi Yang, B.Sc, Liang Piu Koh, M.B.B.S, Veera S Nadarajan, M.B.B.S, Wee-Joo Chng, M.B.Ch.B, Hein Than, M.B.B.S, Lay Cheng Lim, MD, Yeow-Tee Goh, MBBS, MMed, Markus M Nöthen, M.D, Tien Y Wong, M.D, PhD, Atif Shahab, PhD, Xiaoan Ruan, PhD, Valère Cacheux-Rataboul, PhD, Wing-Kin Sung, PhD, Yijun Ruan, PhD, S. Tiong Ong, M.A., M.B.B.Ch., M.R.C.P., (UK)
Journal: Blood
Blood (2011) 118 (21): 1666.
https://doi.org/10.1182/blood.V118.21.1666.1666
Published: 2011